DiRocco Derek — SEC insider filings

SEC reporting owner CIK 1792061. 24 insider filings on record with FilingPulse; latest filed 2026-10-29.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2020-10-21 to 2026-10-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
89bio, Inc. (ETNB)Director6——12
Acrivon Therapeutics, Inc. (ACRV)Director5——5
Mineralys Therapeutics, Inc. (MLYS)Director4——5
Werewolf Therapeutics, Inc. (HOWL)Director4——4
iTeos Therapeutics, Inc. (ITOS)Director4——4
Bambusa Therapeutics, Inc. (BBTX)Director1———

Insider filings — DiRocco Derek

FiledFormIssuerReported transactionsSource
2026-10-293Bambusa Therapeutics, Inc. (BBTX)Holdings only — no transactions reportedEDGAR
2026-06-224Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,275 (derivative) @ $0EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 9,366 @ $0EDGAR
2026-02-204Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2025-10-30489bio, Inc. (ETNB)Disposition to issuer (D): 7,000 (derivative) @ $0 · Disposition to issuer (D): 7,000 (derivative) @ $0 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 27,400 (derivative) @ $0 · Disposition to issuer (D): 45,150 (derivative) @ $0 · +1 moreEDGAR
2025-06-174Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,275 (derivative) @ $0EDGAR
2025-02-244Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 32,900 (derivative) @ $0EDGAR
2025-02-05489bio, Inc. (ETNB)Grant/award (A): 56,400 (derivative) @ $0EDGAR
2024-06-244Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,275 (derivative) @ $0EDGAR
2024-05-244Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2024-05-234Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2024-02-05489bio, Inc. (ETNB)Grant/award (A): 45,150 (derivative) @ $0EDGAR
2023-06-234Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 13,200 (derivative) @ $0EDGAR
2023-06-154iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 22,383 (derivative) @ $0EDGAR
2023-02-13489bio, Inc. (ETNB)Grant/award (A): 27,400 (derivative) @ $0EDGAR
2023-02-134Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 44,000 (derivative) @ $0EDGAR
2022-11-164Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 35,235 (derivative) @ $0EDGAR
2022-06-104iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 17,538 (derivative) @ $0EDGAR
2022-06-034Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 11,600 (derivative) @ $0EDGAR
2022-05-18489bio, Inc. (ETNB)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-06-214iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 16,608 (derivative) @ $0EDGAR
2021-05-044Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 23,200 (derivative) @ $0EDGAR
2021-04-19489bio, Inc. (ETNB)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2020-10-214/AiTeos Therapeutics, Inc. (ITOS)Grant/award (A): 16,608 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1792061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs